Works by Tsai, Ming‐Chang


Results: 79
    1
    2
    3

    Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 9, p. 1508, doi. 10.1111/apt.70029
    By:
    • Chang, Yu‐Ping;
    • Lee, Ji‐Yuh;
    • Chen, Chi‐Yi;
    • Kao, Wei‐Yu;
    • Lin, Chih‐Lin;
    • Yang, Sheng‐Shun;
    • Shih, Yu‐Lueng;
    • Peng, Cheng‐Yuan;
    • Lee, Fu‐Jen;
    • Tsai, Ming‐Chang;
    • Huang, Shang‐Chin;
    • Su, Tung‐Hung;
    • Tseng, Tai‐Chung;
    • Liu, Chun‐Jen;
    • Chen, Pei‐Jer;
    • Kao, Jia‐Horng;
    • Liu, Chen‐Hua
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Enterotype-based Analysis of Gut Microbiota along the Conventional Adenoma-Carcinoma Colorectal Cancer Pathway.

    Published in:
    Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-45588-z
    By:
    • Yang, Tzu-Wei;
    • Lee, Wei-Hsiang;
    • Tu, Siang-Jyun;
    • Huang, Wei-Chih;
    • Chen, Hui-Mei;
    • Sun, Ting-Hsuan;
    • Tsai, Ming-Chang;
    • Wang, Chi-Chih;
    • Chen, Hsuan-Yi;
    • Huang, Chi-Chou;
    • Shiu, Bei-Hao;
    • Yang, Tzu-Ling;
    • Huang, Hsin-Tzu;
    • Chou, Yu-Pao;
    • Chou, Chih-Hung;
    • Huang, Ya-Rong;
    • Sun, Yi-Run;
    • Liang, Chao;
    • Lin, Feng-Mao;
    • Ho, Shinn-Ying
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals.

    Published in:
    Journal of Gastroenterology, 2024, v. 59, n. 7, p. 609, doi. 10.1007/s00535-024-02101-2
    By:
    • Liu, Chen-Hua;
    • Chang, Yu-Ping;
    • Fang, Yu-Jen;
    • Cheng, Pin-Nan;
    • Chen, Chi-Yi;
    • Kao, Wei-Yu;
    • Lin, Chih-Lin;
    • Yang, Sheng-Shun;
    • Shih, Yu-Lueng;
    • Peng, Cheng-Yuan;
    • Tsai, Ming-Chang;
    • Huang, Shang-Chin;
    • Su, Tung-Hung;
    • Tseng, Tai-Chung;
    • Liu, Chun-Jen;
    • Chen, Pei-Jer;
    • Kao, Jia-Horng
    Publication type:
    Article
    47
    48
    49

    Four weeks of off‐treatment follow‐up is sufficient to determine virologic responses at off‐treatment week 12 in patients with hepatitis C virus infection receiving fixed‐dose pangenotypic direct‐acting antivirals.

    Published in:
    Journal of Medical Virology, 2024, v. 96, n. 5, p. 1, doi. 10.1002/jmv.29675
    By:
    • Liu, Chen‐Hua;
    • Chang, Yu‐Ping;
    • Lee, Ji‐Yuh;
    • Chen, Chi‐Yi;
    • Kao, Wei‐Yu;
    • Lin, Chih‐Lin;
    • Yang, Sheng‐Shun;
    • Shih, Yu‐Lueng;
    • Peng, Cheng‐Yuan;
    • Lee, Fu‐Jen;
    • Tsai, Ming‐Chang;
    • Huang, Shang‐Chin;
    • Su, Tung‐Hung;
    • Tseng, Tai‐Chung;
    • Liu, Chun‐Jen;
    • Chen, Pei‐Jer;
    • Kao, Jia‐Horng
    Publication type:
    Article
    50